Cargando…
Editorial Commentary: Comparative Efficacy of Lamivudine and Emtricitabine: Comparing the Results of Randomized Trials and Cohorts
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264583/ https://www.ncbi.nlm.nih.gov/pubmed/25273083 http://dx.doi.org/10.1093/cid/ciu767 |
| _version_ | 1782348766037147648 |
|---|---|
| author | Ford, Nathan Hill, Andrew Vitoria, Marco Mills, Edward J. |
| author_facet | Ford, Nathan Hill, Andrew Vitoria, Marco Mills, Edward J. |
| author_sort | Ford, Nathan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4264583 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42645832014-12-12 Editorial Commentary: Comparative Efficacy of Lamivudine and Emtricitabine: Comparing the Results of Randomized Trials and Cohorts Ford, Nathan Hill, Andrew Vitoria, Marco Mills, Edward J. Clin Infect Dis HIV/AIDS Oxford University Press 2015-01-01 2014-10-01 /pmc/articles/PMC4264583/ /pubmed/25273083 http://dx.doi.org/10.1093/cid/ciu767 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work properly cited. For commercial re-use, please contact journals.permissions@oup.com. |
| spellingShingle | HIV/AIDS Ford, Nathan Hill, Andrew Vitoria, Marco Mills, Edward J. Editorial Commentary: Comparative Efficacy of Lamivudine and Emtricitabine: Comparing the Results of Randomized Trials and Cohorts |
| title | Editorial Commentary: Comparative Efficacy of Lamivudine and Emtricitabine: Comparing the Results of Randomized Trials and Cohorts |
| title_full | Editorial Commentary: Comparative Efficacy of Lamivudine and Emtricitabine: Comparing the Results of Randomized Trials and Cohorts |
| title_fullStr | Editorial Commentary: Comparative Efficacy of Lamivudine and Emtricitabine: Comparing the Results of Randomized Trials and Cohorts |
| title_full_unstemmed | Editorial Commentary: Comparative Efficacy of Lamivudine and Emtricitabine: Comparing the Results of Randomized Trials and Cohorts |
| title_short | Editorial Commentary: Comparative Efficacy of Lamivudine and Emtricitabine: Comparing the Results of Randomized Trials and Cohorts |
| title_sort | editorial commentary: comparative efficacy of lamivudine and emtricitabine: comparing the results of randomized trials and cohorts |
| topic | HIV/AIDS |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264583/ https://www.ncbi.nlm.nih.gov/pubmed/25273083 http://dx.doi.org/10.1093/cid/ciu767 |
| work_keys_str_mv | AT fordnathan editorialcommentarycomparativeefficacyoflamivudineandemtricitabinecomparingtheresultsofrandomizedtrialsandcohorts AT hillandrew editorialcommentarycomparativeefficacyoflamivudineandemtricitabinecomparingtheresultsofrandomizedtrialsandcohorts AT vitoriamarco editorialcommentarycomparativeefficacyoflamivudineandemtricitabinecomparingtheresultsofrandomizedtrialsandcohorts AT millsedwardj editorialcommentarycomparativeefficacyoflamivudineandemtricitabinecomparingtheresultsofrandomizedtrialsandcohorts |